141 related articles for article (PubMed ID: 25408806)
1. Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.
Mano R; Hakimi AA; Zabor EC; Bury MA; Donati OF; Karlo CA; Bazzi WM; Furberg H; Russo P
Can Urol Assoc J; 2014 Sep; 8(9-10):E675-80. PubMed ID: 25408806
[TBL] [Abstract][Full Text] [Related]
2. The Potential of Visceral Adipose Tissue in Distinguishing Clear Cell Renal Cell Carcinoma from Renal Angiomyolipoma with Minimal Fat.
Liu J; Bao J; Zhang W; Li Q; Hou J; Wei X; Huang Y
Cancer Manag Res; 2021; 13():8907-8914. PubMed ID: 34876853
[TBL] [Abstract][Full Text] [Related]
3. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.
Grignol VP; Smith AD; Shlapak D; Zhang X; Del Campo SM; Carson WE
Surg Oncol; 2015 Dec; 24(4):353-8. PubMed ID: 26690825
[TBL] [Abstract][Full Text] [Related]
4. Can Gender-Specific Renal and Visceral Fat Be Evaluated by CT Predict Fuhrman Nuclear Classification of Clear Cell Renal Cell Carcinoma?
Li X; Lin J; Guo Y; Lin D; Zhou J
Curr Med Imaging; 2024 May; ():. PubMed ID: 38798222
[TBL] [Abstract][Full Text] [Related]
5. The value of sex-specific abdominal visceral fat as measured via CT as a predictor of clear renal cell carcinoma T stage.
Guo H; Zhao W; Wang A; Li M; Ma H; Wang F; Wang Q; Ba X
Adipocyte; 2021 Dec; 10(1):285-292. PubMed ID: 34014795
[TBL] [Abstract][Full Text] [Related]
6. Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study.
Himbert C; Ose J; Nattenmüller J; Warby CA; Holowatyj AN; Böhm J; Lin T; Haffa M; Gigic B; Hardikar S; Scherer D; Zielske L; Schrotz-King P; Kölsch T; Siegel EM; Shibata D; Ulrich A; Schneider M; Hursting SD; Kauczor HU; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):76-82. PubMed ID: 30333223
[TBL] [Abstract][Full Text] [Related]
7. Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer.
Slaughter KN; Thai T; Penaroza S; Benbrook DM; Thavathiru E; Ding K; Nelson T; McMeekin DS; Moore KN
Gynecol Oncol; 2014 Apr; 133(1):11-5. PubMed ID: 24680585
[TBL] [Abstract][Full Text] [Related]
8. Clear cell renal cell carcinoma: the value of sex-specific abdominal visceral fat measured on CT for prediction of Fuhrman nuclear grade.
Hu Z; Wu J; Lai S; Xu Y; Zhan J; Li R; Liu X; Wang N; Wei X; Jiang X; Yang R
Eur Radiol; 2020 Jul; 30(7):3977-3986. PubMed ID: 32144457
[TBL] [Abstract][Full Text] [Related]
9. Elevated visceral obesity quantified by CT is associated with adverse postoperative outcome of laparoscopic radical nephrectomy for renal clear cell carcinoma patients.
Zhai T; Zhang B; Qu Z; Chen C
Int Urol Nephrol; 2018 May; 50(5):845-850. PubMed ID: 29611145
[TBL] [Abstract][Full Text] [Related]
10. CT-based assessment of visceral adiposity and outcomes for esophageal adenocarcinoma.
Saeed N; Shridhar R; Almhanna K; Hoffe S; Chuong M; Meredith K
J Gastrointest Oncol; 2017 Oct; 8(5):833-841. PubMed ID: 29184687
[TBL] [Abstract][Full Text] [Related]
11. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.
Guiu B; Petit JM; Bonnetain F; Ladoire S; Guiu S; Cercueil JP; Krausé D; Hillon P; Borg C; Chauffert B; Ghiringhelli F
Gut; 2010 Mar; 59(3):341-7. PubMed ID: 19837679
[TBL] [Abstract][Full Text] [Related]
12. Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma.
Ballian N; Lubner MG; Munoz A; Harms BA; Heise CP; Foley EF; Kennedy GD
J Surg Oncol; 2012 Mar; 105(4):365-70. PubMed ID: 21751219
[TBL] [Abstract][Full Text] [Related]
13. Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China.
Wang HK; Song XS; Cheng Y; Qu YY; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu YP; Shi GH; Qin XJ; Ma CG; Lin GW; Xiao WJ; Zhu Y; Ye DW
BJU Int; 2014 Oct; 114(4):496-502. PubMed ID: 25383400
[TBL] [Abstract][Full Text] [Related]
14. Influence of abdominal fat distribution and inflammatory status on post-operative prognosis in non-small cell lung cancer patients: a retrospective cohort study.
Ma M; Luo M; Liu Q; Zhong D; Liu Y; Zhang K
J Cancer Res Clin Oncol; 2024 Mar; 150(3):111. PubMed ID: 38431748
[TBL] [Abstract][Full Text] [Related]
15. Adipose Tissue Distribution and Body Mass Index (BMI) Correlation With Daily Image-Guided Radiotherapy (IGRT) Shifts of Abdominal Radiation Therapy Patients.
Price RG; Lloyd S; Wang X; Haaland B; Nelson G; Salter B
Cureus; 2023 Jun; 15(6):e40979. PubMed ID: 37503478
[TBL] [Abstract][Full Text] [Related]
16. Association between Visceral or Subcutaneous Fat Accumulation and B-Type Natriuretic Peptide among Japanese Subjects: A Cross-Sectional Study.
Hayashi Y; Yokokawa H; Fukuda H; Saita M; Miyagami T; Takahashi Y; Hisaoka T; Naito T
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33806735
[TBL] [Abstract][Full Text] [Related]
17. Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis.
Esposito A; Marra A; Bagnardi V; Frassoni S; Morganti S; Viale G; Zagami P; Varano GM; Buccimazza G; Orsi F; Venetis K; Mazzarella L; Viale G; Fusco N; Criscitiello C; Curigliano G
Eur J Cancer; 2021 Mar; 145():197-209. PubMed ID: 33493979
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of visceral obesity on gastric adenocarcinoma: does it really matter?
Gürsoy Çoruh A; Uzun Ç; Akkaya Z; Avcı O; Adıgüzel M; Ersöz CC; Elhan AH
Clin Imaging; 2021 Aug; 76():228-234. PubMed ID: 33971589
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle and visceral adipose radiodensities are pre-surgical, non-invasive markers of aggressive kidney cancer.
Furberg H; Bradshaw PT; Knezevic A; Olsson L; Petruzella S; Stein E; Paris M; Scott J; Akin O; Hakimi AA; Russo P; Sanchez A; Caan B; Mourtzakis M
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):726-734. PubMed ID: 38263932
[TBL] [Abstract][Full Text] [Related]
20. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients.
Odamaki M; Furuya R; Ohkawa S; Yoneyama T; Nishikino M; Hishida A; Kumagai H
Nephrol Dial Transplant; 1999 Oct; 14(10):2427-32. PubMed ID: 10528668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
